Open AccessBeadArray™-based solutions for enabling the promise of pharmacogenomics
Author(s) -
JianBing Fan,
Sean X. Hu,
William C. Craumer,
David Barker
Publication year - 2005
Publication title -
biotechniques/biotechniques
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.617
H-Index - 131
eISSN - 1940-9818
pISSN - 0736-6205
DOI - 10.2144/000112047
Subject(s) - pharmacogenomics , personalized medicine , health care , precision medicine , paradigm shift , data science , key (lock) , genomics , big data , computer science , medicine , bioinformatics , political science , data mining , biology , genome , pharmacology , computer security , genetics , gene , law , philosophy , epistemology , pathology
A “one-size-fits-all” approach continues to characterize today's healthcare paradigm. But emergent rules, information, genomics tools, and economics are driving a fundamental and inevitable shift to a more personalized world of medicine. In this new world, the interests of insurers, regulators, suppliers, healthcare providers, and most important, patients, will have converged. The new goal will be the right treatment for the right individual at the right time. In this world, personalized medicine, through pharmacogenomics (PGx), will be the new healthcare paradigm. We will briefly examine healthcare trends and current opportunities for PGx development. We will then demonstrate how microarray technologies—among them bead-based approaches—have emerged as a key enablerfor bringing home the promise of PGx.